印度改变脊髓灰质炎根除策略带来的疲劳和恐惧：对疫苗接种社会抵制的研究。
Fatigue and fear with shifting polio eradication strategies in India: a study of social resistance to vaccination.
机构信息
Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
出版信息
PLoS One. 2012;7(9):e46274. doi: 10.1371/journal.pone.0046274. Epub 2012 Sep 26.
Abstract
Shifting polio eradication strategies may have generated fear and "resistance" to the eradication program in Aligarh, India during the summer of 2009. Participant observation and formal interviews with 107 people from May to August 2009 indicated that the intensified frequency of vaccination was correlated with patients' doubt in the efficacy of the vaccine. This doubt was exacerbated in a few cases as families were uninformed of the use of monovalent mOPV1, while P3 cases continued to occur. Many families had also come to believe that their children had been adversely affected by OPV after being told the vaccine carried no risk. Though polio is now largely eradicated in India, with only a single case in 2011, greater transparency about changes with vaccination policy may need to be considered to build trust with the public in future eradication programs.
摘要
2009 年夏季，印度阿拉哈巴德改变脊髓灰质炎根除策略，可能引发民众对根除计划的恐惧和“抵触”。2009 年 5 月至 8 月，通过对 107 人进行参与性观察和正式访谈发现，疫苗接种频率的增加与患者对疫苗效果的怀疑有关。在少数情况下，由于未告知使用单价 mOPV1，而 P3 病例仍在继续发生，家庭对此表示怀疑。许多家庭还认为，在被告知疫苗没有风险后，他们的孩子接种 OPV 后受到了不良影响。尽管印度目前已基本根除脊髓灰质炎，2011 年仅出现一例病例，但未来根除计划可能需要考虑提高疫苗接种政策变化的透明度，以赢得公众的信任。
相似文献
1
Fatigue and fear with shifting polio eradication strategies in India: a study of social resistance to vaccination.
PLoS One. 2012;7(9):e46274. doi: 10.1371/journal.pone.0046274. Epub 2012 Sep 26.
2
OPV cannot eradicate polio from India: do we need any further evidence?
Vaccine. 2008 Apr 16;26(17):2058-61. doi: 10.1016/j.vaccine.2008.02.054. Epub 2008 Mar 14.
3
Partition and poliomyelitis: an investigation of the polio disparity affecting Muslims during India's eradication program.
PLoS One. 2015 Mar 5;10(3):e0115628. doi: 10.1371/journal.pone.0115628. eCollection 2015.
4
Polio eradication in India: current status.
J Indian Med Assoc. 2005 Dec;103(12):669-70, 678.
5
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
Lancet Infect Dis. 2012 Feb;12(2):128-35. doi: 10.1016/S1473-3099(11)70190-6. Epub 2011 Nov 7.
6
Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
MMWR Morb Mortal Wkly Rep. 2007 Mar 30;56(12):278-81.
7
Role of genetic factors in polio eradication: new challenge for policy makers.
Vaccine. 2007 Dec 5;25(50):8365-71. doi: 10.1016/j.vaccine.2007.09.068. Epub 2007 Oct 17.
8
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
9
Some ethical issues arising from polio eradication programmes in India.
Bioethics. 2005 Aug;19(4):393-406. doi: 10.1111/j.1467-8519.2005.00451.x.
10
The polio endgame.
Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115.
引用本文的文献
1
Quantifiable Cross-cultural Research on Medical Mistrust is Necessary for Effective and Equitable Vaccination in Low- and Middle-income Countries.
J Epidemiol Glob Health. 2024 Dec;14(4):1771-1777. doi: 10.1007/s44197-024-00319-0. Epub 2024 Oct 28.
2
From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2389578. doi: 10.1080/21645515.2024.2389578. Epub 2024 Aug 22.
3
A Low-Cost, Integrated Immunization, Health, and Nutrition Intervention in Conflict Settings in Pakistan-The Impact on Zero-Dose Children and Polio Coverage.
Pathogens. 2024 Feb 20;13(3):185. doi: 10.3390/pathogens13030185.
4
Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames.
PLoS One. 2023 Feb 10;18(2):e0279809. doi: 10.1371/journal.pone.0279809. eCollection 2023.
5
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
6
A multi-pronged scoping review approach to understanding the evolving implementation of the Smallpox and Polio eradication programs: what can other Global Health initiatives learn?
BMC Public Health. 2020 Dec 18;20(Suppl 4):1698. doi: 10.1186/s12889-020-09439-1.
7
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
8
Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
J Infect Dis. 2016 May 1;213 Suppl 3(Suppl 3):S91-5. doi: 10.1093/infdis/jiv510. Epub 2015 Nov 25.
9
Partition and poliomyelitis: an investigation of the polio disparity affecting Muslims during India's eradication program.
PLoS One. 2015 Mar 5;10(3):e0115628. doi: 10.1371/journal.pone.0115628. eCollection 2015.
10
Sustaining motivation to immunize: exchanging lessons between India and the United States.
Hum Vaccin Immunother. 2014;10(10):2930-4. doi: 10.4161/hv.29871.
本文引用的文献
1
Polio Eradication in India: Myth or Reality.
Med J Armed Forces India. 2005 Oct;61(4):364-6. doi: 10.1016/S0377-1237(05)80069-3. Epub 2011 Jul 21.
2
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.
Lancet. 2010 Nov 13;376(9753):1682-8. doi: 10.1016/S0140-6736(10)61230-5. Epub 2010 Oct 25.
3
Using data to guide action in polio health communications: experience from the Polio Eradication Initiative (PEI).
J Health Commun. 2010;15 Suppl 1:48-65. doi: 10.1080/10810731003698585.
4
The complexity of social mobilization in health communication: top-down and bottom-up experiences in polio eradication.
J Health Commun. 2010;15 Suppl 1:25-47. doi: 10.1080/10810731003695367.
5
Deconstructing social resistance to pulse polio campaign in two North Indian districts.
Indian Pediatr. 2009 Nov;46(11):963-74. Epub 2009 Sep 3.
6
Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
MMWR Morb Mortal Wkly Rep. 2009 Apr 3;58(12):308-12.
7
Social determinants and polio 'endgame': a qualitative study in high risk districts of India.
Indian Pediatr. 2008 May;45(5):357-65.
8
Reducing resistance against polio drops.
J R Soc Promot Health. 2007 Nov;127(6):276-9. doi: 10.1177/1466424007083705.
9
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.
Lancet. 2007 Apr 21;369(9570):1356-1362. doi: 10.1016/S0140-6736(07)60531-5.
10
Infectious disease. Polio: no cheap way out.
Science. 2007 Apr 20;316(5823):362-3. doi: 10.1126/science.316.5823.362.
Zotero 插件